Nvidia Options Price in $280 Billion Earnings Swing 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Shein Launches $1.77 Billion Hong Kong IPO After Years of Listing Delays 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
California Seeks Paramount Divestitures in Warner Bros. Merger 
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
Nvidia Eyes Perplexity Investment at $30 Billion Valuation 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
Ampol Profit Surges as Refining Margins Hit Record Highs 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
SK Hynix Shares Fall as Workers Reject Wage Deal 
KPMG Australia Cuts 5% of Workforce Amid Scandal 
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 
Add as a preferred source on Google
NEW YORK, May 01, 2018 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akorn, Inc. (NASDAQ:AKRX) from March 1, 2017 through February 26, 2018, both dates inclusive (“Class Period”) of the important May 7, 2018 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Akorn investors under the federal securities laws.
To join the Akorn class action, go to http://www.rosenlegal.com/cases-1301.html or call Phillip Kim, Esq. or Zachary Halper, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Akorn’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’s acquisition of Akorn; (2) Akorn lacked effective internal controls over financial reporting; and (3) as a result, Akorn’s financial statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 7, 2018. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1301.html to join the class action. You may also contact Phillip Kim or Zachary Halper of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. The Rosen Law Firm was Ranked No. 1 by Institutional Shareholder Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Zachary Halper, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
